C. Daniel Myers's Insider Trades & SAST Disclosures

C. Daniel Myers's most recent trade in Kala Pharmaceuticals Inc was a trade of 5,450 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2025.

Share

Note

This is a custom search result for pattern C. Daniel Myers.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2025	5,450	5,450	-		-	Stock Option (right to buy)
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2025	2,450	10,374 (0%)	0%		0	Common Stock
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	3,150	3,150	-		-	Stock Option (right to buy)
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	1,400	7,924 (0%)	0%		0	Common Stock
Alimera Sciences Inc.	C. Daniel Myers	Chairman Emeritus	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Aug 2023	6,000	6,000	-		-	Stock Option (Right to Buy)
Alimera Sciences Inc.	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2023	6,000	6,000	-		-	Stock Option (Right to Buy)
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2022	40,000	40,000	-		-	Stock Option (right to buy)
Alimera Sciences Inc.	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2021	6,000	6,000	-		-	Common Stock
Kala Pharmaceuticals Inc Board Meeting 52 week high High Gain High Volume	C. Daniel Myers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Oct 2021	42,000	42,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades